Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
J Mol Recognit ; 34(10): e2922, 2021 10.
Artículo en Inglés | MEDLINE | ID: mdl-34132435

RESUMEN

Using a rat model of peritonitis, we herein report the inflammatory effect induced by the lectin isolated from Vatairea guianensis (VGL) seeds in the context of interactions between VGL and both toll-like receptor 4 (TLR4) and tumor necrosis factor receptor 1 (TNFR1). Peritoneal macrophages were stimulated with VGL for dose-dependent gene expression and release of TNF-α. In vivo results showed that VGL (1 mg/kg; intraperitoneal) induced peritonitis in female Wistar rats. Leukocyte migration, macrophage activation, and protein leakage were measured 3 and 6 hours after induction. In vitro, peritoneal macrophages were stimulated with VGL for gene expression and TNF-α dosage (mean ± SEM (n = 6), analysis of variance, and Bonferroni's test (P < .05)). In silico, VGL structure was applied in molecular docking with representative glycans. It was found that (a) VGL increases vascular permeability and stimulates leukocyte migration, both rolling and adhesion; (b) lectin-induced neutrophil migration occurs via macrophage stimulation, both in vitro and in vivo; (c) lectin interacts with TLR4 and TNFR1; and (d) stimulates TNF-α gene expression (RT-PCR) and release from peritoneal macrophages. Thus, upon lectin-glycan binding on the cell surface, our results suggest that VGL induces an acute inflammatory response, in turn activating the release of peritoneal macrophages via TNF-α and TLR and/or TNFR receptor pathways.


Asunto(s)
Fabaceae/química , Glicoconjugados/metabolismo , Macrófagos Peritoneales/efectos de los fármacos , Lectinas de Plantas/farmacología , Animales , Movimiento Celular/efectos de los fármacos , Células Cultivadas , Modelos Animales de Enfermedad , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Glicoconjugados/química , Leucocitos/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , Peritonitis/inducido químicamente , Peritonitis/metabolismo , Peritonitis/patología , Lectinas de Plantas/química , Lectinas de Plantas/metabolismo , Ratas Wistar , Receptores Tipo I de Factores de Necrosis Tumoral/química , Receptores Tipo I de Factores de Necrosis Tumoral/metabolismo , Receptor Toll-Like 4/metabolismo , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/metabolismo
2.
J Cell Biochem ; 116(8): 1668-79, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-25735873

RESUMEN

The development of the mammary gland involves formation of a branched arboreal structure resulting from the penetration and proliferation of epithelial cells into the fat pad. The mammary cells invade by remodeling their surrounding extracellular matrix (ECM), which are rich in proteins, and glycans such as heparan sulfate proteoglycans (HSPGs). There is increasing literature on how the interaction between signaling by ECM and matrix metalloproteinases (MMPs) is relevant to morphogenetic and physiological contexts. Here we sought to understand how heparanase, the sole mammalian heparan sulfate-degrading endoglycosidase may regulate mammary gland development. We found a robust localization of heparanase within growing end buds during branching in vivo. Using three-dimensional (3D) organotypic cultures, we showed that heparanase expression and activity are required for mammary epithelial invasion/branching within dense collagen I gels. Morphometric analysis of glands from both heparanase-overexpressing and knockout mice showed a direct correlation between degree of branching and the heparanase levels, confirming our 3D organotypic culture observations. Finally, we uncovered a reciprocal association between levels of heparanase and MMP14, a membrane-bound MMP, shedding further light on how branching occurs within developing mammary glands.


Asunto(s)
Glucuronidasa/metabolismo , Glándulas Mamarias Animales/crecimiento & desarrollo , Metaloproteinasa 14 de la Matriz/metabolismo , Morfogénesis , Animales , Movimiento Celular , Células Epiteliales/fisiología , Femenino , Regulación del Desarrollo de la Expresión Génica , Glucuronidasa/genética , Glándulas Mamarias Animales/enzimología , Ratones , Técnicas de Cultivo de Órganos , Transducción de Señal
3.
Glycobiology ; 25(4): 386-93, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25367817

RESUMEN

Inflammation and cancer are related pathologies acting synergistically to promote tumor progression. In both, hematogenous metastasis and inflammation, P-selectin participates in interactions involving tumor cells, platelets, leukocytes and endothelium. Heparin has been shown to inhibit P-selectin and as a consequence it blunts metastasis and inflammation. Some heparin analogs obtained from marine invertebrates are P-selectin inhibitors and do not induce bleeding effects. The present work focuses on the P-selectin blocking activity of a unique heparan sulfate (HS) from the bivalve mollusk Nodipecten nodosus. Initially, we showed that the mollusk HS inhibited LS180 colon carcinoma cell adhesion to immobilized P-selectin in a dose-dependent manner. In addition, we demonstrated that this glycan attenuates leukocyte rolling on activated endothelium and inflammatory cell recruitment in thioglycollate-induced peritonitis in mice. Biochemical analysis indicated that the invertebrate glycan also inhibits heparanase, a key player in cell invasion and metastasis. Experimental metastasis of Lewis lung carcinoma cells was drastically attenuated by the mollusk HS through a mechanism involving inhibition of platelet-tumor-cell complex formation in blood vessels. These data suggest that the mollusk HS is a potential alternative to heparin for inhibiting P-selectin-mediated events such as metastasis and inflammatory cell recruitment.


Asunto(s)
Antineoplásicos/farmacología , Carcinoma Pulmonar de Lewis/tratamiento farmacológico , Heparitina Sulfato/farmacología , Neoplasias Pulmonares/prevención & control , Animales , Anticoagulantes/farmacología , Antineoplásicos/uso terapéutico , Plaquetas/efectos de los fármacos , Plaquetas/fisiología , Carcinoma Pulmonar de Lewis/secundario , Adhesión Celular , Línea Celular Tumoral , Ensayos de Selección de Medicamentos Antitumorales , Glucuronidasa/antagonistas & inhibidores , Glucuronidasa/química , Heparitina Sulfato/uso terapéutico , Humanos , Concentración 50 Inhibidora , Rodamiento de Leucocito/efectos de los fármacos , Neoplasias Pulmonares/secundario , Moluscos , Trasplante de Neoplasias , Selectina-P/antagonistas & inhibidores , Selectina-P/metabolismo
4.
Biochim Biophys Acta ; 1840(8): 2599-608, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-24747732

RESUMEN

BACKGROUND: Heparanase is the only known mammalian glycosidase capable of cleaving heparan sulfate chains. The expression of this enzyme has been associated with tumor development because of its ability to degrade extracellular matrix and promote cell invasion. METHODS: We analyzed heparanase expression in lung cancer samples to understand lung tumor progression and malignancy. Of the samples from 37 patients, there were 14 adenocarcinomas, 13 squamous cell carcinomas, 5 large cell carcinomas, and 5 small cell carcinomas. Immunohistochemistry was performed to ascertain the expression and localization of heparanase. RESULTS: All of the tumor types expressed heparanase, which was predominantly localized within the cytoplasm and nucleus. Significant enzyme expression was also observed in cells within the tumor microenvironment, such as fibroblasts, epithelial cells, and inflammatory cells. Adenocarcinomas exhibited the strongest heparanase staining intensity and the most widespread heparanase distribution. Squamous cell carcinomas, large cell carcinomas, and small cell carcinomas had a similar subcellular distribution of heparanase to adenocarcinomas but the distribution was less widespread. Heparanase expression tended to correlate with tumor node metastasis (TNM) staging in non-small cell lung carcinoma. CONCLUSION: In this study, we showed that heparanase was localized to the cytoplasm and nucleus of tumor cells and to cells within the microenvironment in different types of lung cancer. This enzyme exhibited a differential distribution based on the type of lung tumor. General significance Elucidating the heparanase expression patterns in different types of lung cancer increased our understanding of the crucial role of heparanase in lung cancer biology. This article is part of a Special Issue entitled Matrix-mediated cell behaviour and properties.


Asunto(s)
Glucuronidasa/metabolismo , Neoplasias Pulmonares/clasificación , Neoplasias Pulmonares/enzimología , Adenocarcinoma/enzimología , Adenocarcinoma/patología , Diferenciación Celular , Membrana Celular/enzimología , Núcleo Celular/enzimología , Núcleo Celular/patología , Femenino , Humanos , Neoplasias Pulmonares/patología , Linfocitos/enzimología , Macrófagos/enzimología , Masculino , Persona de Mediana Edad , Metástasis de la Neoplasia , Estadificación de Neoplasias , Transporte de Proteínas , Coloración y Etiquetado , Microambiente Tumoral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...